Glastonbury, CT, United States of America

Sai Chetan K Sukuru

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sai Chetan K Sukuru. Retrieved from https://idiyas.com/inventor/sai-chetan-k-sukuru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Inventor Sai Chetan K Sukuru

Introduction: Sai Chetan K Sukuru is an accomplished inventor based in Glastonbury, Connecticut. He has made significant contributions to the field of medical science, particularly in the development of novel therapeutic agents.

Latest Patents: Sai Chetan K Sukuru holds a patent for "Tubulysin analogs and methods for their preparation." This invention focuses on novel cytotoxic tubulysin analogs and derivatives, as well as antibody drug conjugates. The methods developed aim to treat various medical conditions, including cancer.

Career Highlights: Sai Chetan K Sukuru is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to engage in cutting-edge research and development in the pharmaceutical industry.

Collaborations: Throughout his career, Sai has collaborated with notable colleagues, including Chakrapani Subramanyam and Lawrence Nathan Tumey. These collaborations have contributed to the advancement of innovative solutions in medical treatments.

Conclusion: Sai Chetan K Sukuru's contributions to the field of medicine through his inventions and collaborations highlight his dedication to improving healthcare outcomes. His work continues to inspire future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…